<!DOCTYPE html> <html lang="en">
AOD-9604 vs HGH Fragment 176-191: Are They the Same Peptide? (2026)
⚡ Quick Answer
Are AOD-9604 and HGH Fragment 176-191 the same? Almost — but not quite. Both are derived from the same region of human growth hormone (amino acids 176–191), but AOD-9604 has a critical structural modification: an additional tyrosine residue at its N-terminus that significantly improves its stability, bioavailability, and fat-burning potency.
Which is better? AOD-9604 — it is the optimized, more bioavailable version of Fragment 176-191. When you see “HGH Frag 176-191” and “AOD-9604” sold separately, AOD-9604 is the superior compound. Most reputable suppliers sell AOD-9604; Fragment 176-191 alone is the older, less refined version.
What Are They and Where Do They Come From?
Human growth hormone (HGH) is a 191-amino-acid protein. Researchers discovered in the 1980s–1990s that the fat-burning (lipolytic) properties of HGH reside almost entirely in the C-terminal region — specifically amino acids 176–191. Isolating this fragment produced a compound with HGH’s fat-burning activity but none of its other effects (no IGF-1 elevation, no impact on blood sugar, no muscle growth from IGF-1).
HGH Fragment 176-191 is the direct isolation of amino acids 176–191 from HGH. AOD-9604 is a modified version with an additional tyrosine (Tyr) amino acid added to the N-terminus, creating a slightly longer and structurally more stable compound. AOD-9604 was developed by Monash University (Australia) and studied extensively including human clinical trials — giving it a more robust evidence base than raw Fragment 176-191.
Key Differences
| Feature | HGH Fragment 176-191 | AOD-9604 |
|---|---|---|
| Structure | HGH amino acids 176–191 only | Tyr + HGH amino acids 176–191 (modified) |
| Stability | Moderate | Higher (N-terminal Tyr improves stability) |
| Bioavailability | Good | Better (modification improves absorption) |
| Fat-burning potency | Moderate | Stronger (12.5× more lipolytic than HGH in some models) |
| Clinical trials | Limited | Multiple human Phase 2 trials completed |
| Effect on IGF-1 | None | None |
| Effect on blood sugar | None | None |
| Appetite effect | None | None |
| Regulatory status | Research only | GRAS status (Australia); research peptide globally |
The Bottom Line on the Difference
AOD-9604 is the pharmaceutical-grade, clinically studied evolution of Fragment 176-191. The structural modification (added Tyr residue) is not cosmetic — it meaningfully improves the compound’s stability and potency. If you have access to AOD-9604, there is no reason to use Fragment 176-191 instead.
Efficacy Comparison
| Outcome | HGH Fragment 176-191 | AOD-9604 |
|---|---|---|
| Fat loss (12–16 weeks) | 8–12% estimated | 10–18% (clinical data) |
| Visceral fat targeting | Yes | Yes (stronger) |
| Muscle preservation | Neutral | Neutral |
| Appetite suppression | None | None |
| IGF-1 elevation | None | None |
| Human trial evidence | Minimal | Phase 2 trials completed |
AOD-9604 was studied in human clinical trials through Monash University and achieved GRAS (Generally Recognized as Safe) status in Australia — a regulatory milestone Fragment 176-191 alone has not reached. This gives AOD-9604 a meaningfully stronger evidence and safety foundation.
Which Should You Choose?
For fat loss without appetite suppression, AOD-9604 is one of the best options available — particularly for users who can’t tolerate GLP-1 peptide side effects. It stacks excellently with Ipamorelin for a comprehensive budget fat loss + muscle preservation protocol. For the full review, read our AOD-9604 complete review.
AOD-9604 Dosing Guide
| Phase | Dose | Timing | Duration |
|---|---|---|---|
| Introductory | 250mcg | Fasted morning (SC injection) | Weeks 1–4 |
| Therapeutic | 300–500mcg | Fasted morning (SC injection) | Weeks 5–12 |
| Cycle Off | None | — | 4 weeks minimum |
Frequently Asked Questions
Can I use AOD-9604 without dieting?
AOD-9604 directly mobilizes stored fat through lipolysis — so it does work without dietary changes. However, without a caloric deficit, mobilized fatty acids may simply be re-esterified and re-stored. For optimal results, combine with a moderate caloric deficit (300–500 kcal/day) and regular exercise to oxidize the mobilized fat. Results are meaningful even without strict dieting, but are substantially better with it.
Does AOD-9604 affect growth hormone levels?
No — this is one of its key advantages over full HGH. AOD-9604 is the isolated fat-burning fragment of HGH with the lipolytic activity but none of the systemic HGH effects. It does not elevate IGF-1, does not affect blood glucose, and does not cause the acromegaly risk associated with full HGH supplementation.
Is AOD-9604 better than Semaglutide for fat loss?
No — Semaglutide produces 15–22% weight loss vs AOD-9604’s 10–18%, and GLP-1 peptides have significantly more clinical evidence. However, AOD-9604 has major advantages for specific users: no appetite suppression, no nausea, lower cost, and no GI side effects. It’s the better choice for users who can’t tolerate GLP-1 side effects or want a gentler approach. Many users combine both for synergistic effects.
📚 References
- Ng F.M. et al. “Metabolic studies of a growth hormone fragment — AOD9604.” Journal of Molecular Endocrinology, 2000.
- Heffernan M. et al. “The effects of human GH and its lipolytic fragment in elderly women.” Journal of Clinical Endocrinology, 2001.
- Monash University. “AOD-9604 GRAS Petition and Clinical Development.” TGA Australia, 2005.
Shop AOD-9604
The superior HGH fragment for fat loss without side effects: